The Staphylococcus aureus Thiol/Oxidative stress global regulator Spx controls trfA, a gene implicated in cell wall antibiotic resistance

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 7, 2013, Pages 3283-3292

  Jousselin, Ambre ^a   Kelley, William L ^a   Barras, Christine ^a   Lew, Daniel P ^a   Renzoni, Adriana ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CIPROFLOXACIN; COMPLEMENTARY DNA; CYCLOSERINE; DIAMIDE; OXACILLIN; SIGB PROTEIN; SPX PROTEIN; STK1 PROTEIN; STP1 PROTEIN; TEICOPLANIN; TEICOPLANIN DERIVATIVE; TRFA PROTEIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIUM ISOLATE; GENE EXPRESSION; GENE SEQUENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NORTHERN BLOTTING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; UPREGULATION; WESTERN BLOTTING;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CELL WALL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; MEMBRANE PROTEINS; METHICILLIN RESISTANCE; MOLECULAR SEQUENCE DATA; OXACILLIN; OXIDATIVE STRESS; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCUS AUREUS; SULFHYDRYL COMPOUNDS; TRANSCRIPTION, GENETIC;

EID: 84879008573     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00220-13     Document Type: Article

References (74)

1. Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
2. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. 2010. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin. Microbiol. Rev. 23:99-139.
3. Gould IM, Cauda R, Esposito S, Gudiol F, Mazzei T, Garau J. 2011. Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits? Int. J. Antimicrob. Agents 37:202-209.
4. Kullar R, Davis SL, Levine DP, Rybak MJ. 2011. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin. Infect. Dis. 52:975-981.
5. Tenover FC, Sinner SW, Segal RE, Huang V, Alexandre SS, McGowan JE, Jr, Weinstein MP. 2009. Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy. Int. J. Antimicrob. Agents 33:564-568.
6. Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM, Stellrecht K. 2008. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob. Agents Chemother. 52: 3315-3320.
7. Perichon B, Courvalin P. 2009. VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53:4580-4587.
8. Zhu W, Murray PR, Huskins WC, Jernigan JA, McDonald LC, Clark NC, Anderson KF, McDougal LK, Hageman JC, Olsen-Rasmussen M, Frace M, Alangaden GJ, Chenoweth C, Zervos MJ, Robinson-Dunn B, Schreckenberger PC, Reller LB, Rudrik JT, Patel JB. 2010. Dissemination of an Enterococcus Inc18-like vanA plasmid, associated with vancomycin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 54:4314-4320.
9. Berger-Bachi B, McCallum N. 2006. State of the knowledge of bacterial resistance. Injury 37(Suppl. 2):S20-S25.
10. Renzoni A, Andrey DO, Jousselin A, Barras C, Monod A, Vaudaux P, Lew D, Kelley WL. 2011. Whole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in Staphylococcus aureus. PLoS One 6:e21577. doi:10.1371/journal.pone.0021577.
11. Maki H, McCallum N, Bischoff M, Wada A, Berger-Bachi B. 2004. tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 48:1953-1959. (Pubitemid 38691582)
12. Kuroda M, Kuwahara-Arai K, Hiramatsu K. 2000. Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. Biochem. Biophys. Res. Commun. 269:485-490. (Pubitemid 30440327)
13. Meehl M, Herbert S, Gotz F, Cheung A. 2007. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 51:2679-2689. (Pubitemid 47206200)
14. Renzoni A, Kelley WL, Barras C, Monod A, Huggler E, Francois P, Schrenzel J, Studer R, Vaudaux P, Lew DP. 2009. Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 53:903-911.
15. Kramer N, Hahn J, Dubnau D. 2007. Multiple interactions among the competence proteins of Bacillus subtilis. Mol. Microbiol. 65:454-464. (Pubitemid 47052728)
16. Dubnau D, Roggiani M. 1990. Growth medium-independent genetic competence mutants of Bacillus subtilis. J. Bacteriol. 172:4048-4055. (Pubitemid 20213391)
17. Rashid MH, Tamakoshi A, Sekiguchi J. 1996. Effects of mecA and mecB (clpC) mutations on expression of sigD, which encodes an alternative sigma factor, and autolysin operons and on flagellin synthesis in Bacillus subtilis. J. Bacteriol. 178:4861-4869. (Pubitemid 26321286)
18. Kirstein J, Schlothauer T, Dougan DA, Lilie H, Tischendorf G, Mogk A, Bukau B, Turgay K. 2006. Adaptor protein controlled oligomerization activates the AAA+ protein ClpC. EMBO J. 25:1481-1491.
19. Kock H, Gerth U, Hecker M. 2004. MurAA, catalysing the first committed step in peptidoglycan biosynthesis, is a target of Clp-dependent proteolysis in Bacillus subtilis. Mol. Microbiol. 51:1087-1102. (Pubitemid 38270801)
20. Kruger E, Zuhlke D, Witt E, Ludwig H, Hecker M. 2001. Clp-mediated proteolysis in Gram-positive bacteria is autoregulated by the stability of a repressor. EMBO J. 20:852-863. (Pubitemid 32167649)
21. Nakano S, Zheng G, Nakano MM, Zuber P. 2002. Multiple pathways of Spx (YjbD) proteolysis in Bacillus subtilis. J. Bacteriol. 184:3664-3670. (Pubitemid 34625676)
22. Turgay K, Hamoen LW, Venema G, Dubnau D. 1997. Biochemical characterization of a molecular switch involving the heat shock protein ClpC, which controls the activity of ComK, the competence transcription factor of Bacillus subtilis. Genes Dev. 11:119-128. (Pubitemid 27043829)
23. Vaudaux P, Francois P, Bisognano C, Kelley WL, Lew DP, Schrenzel J, Proctor RA, McNamara PJ, Peters G, Von Eiff C. 2002. Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect. Immun. 70:5428-5437.
24. Galbusera E, Renzoni A, Andrey DO, Monod A, Barras C, Tortora P, Polissi A, Kelley WL. 2011. Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance. Antimicrob. Agents Chemother. 55: 1008-1020.
25. Renzoni A, Francois P, Li D, Kelley WL, Lew DP, Vaudaux P, Schrenzel J. 2004. Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 48:2958-2965. (Pubitemid 38989161)
26. Kelley WL, Georgopoulos C. 1997. Positive control of the twocomponent RcsC/B signal transduction network by DjlA: a member of the DnaJ family of molecular chaperones in Escherichia coli. Mol. Microbiol. 25:913-931. (Pubitemid 27397520)
27. Uckay I, Bernard L, Buzzi M, Harbarth S, Francois P, Huggler E, Ferry T, Schrenzel J, Renzoni A, Vaudaux P, Lew DP. 2012. High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 56:1258-1264.
28. Yin S, Daum RS, Boyle-Vavra S. 2006. VraSR two-component regulatory system and its role in induction of pbp2 and vraSR expression by cell wall antimicrobials in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:336-343. (Pubitemid 43042941)
29. Utaida S, Dunman PM, Macapagal D, Murphy E, Projan SJ, Singh VK, Jayaswal RK, Wilkinson BJ. 2003. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149:2719-2732. (Pubitemid 37279247)
30. Pamp SJ, Frees D, Engelmann S, Hecker M, Ingmer H. 2006. Spx is a global effector impacting stress tolerance and biofilm formation in Staphylococcus aureus. J. Bacteriol. 188:4861-4870. (Pubitemid 43956084)
31. ten Broeke-Smits NJ, Pronk TE, Jongerius I, Bruning O, Wittink FR, Breit TM, van Strijp JA, Fluit AC, Boel CH. 2010. Operon structure of Staphylococcus aureus. Nucleic Acids Res. 38:3263-3274.
32. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49:807-821. (Pubitemid 36918698)
33. Delaune A, Dubrac S, Blanchet C, Poupel O, Mader U, Hiron A, Leduc A, Fitting C, Nicolas P, Cavaillon JM, Adib-Conquy M, Msadek T. 2012. The WalKR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response. Infect. Immun. 80:3438-3453.
34. Giachino P, Engelmann S, Bischoff M. 2001. Sigma(B) activity depends on RsbU in Staphylococcus aureus. J. Bacteriol. 183:1843-1852. (Pubitemid 32225979)
35. Kullik I, Giachino P, Fuchs T. 1998. Deletion of the alternative sigma factor sigmaB in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J. Bacteriol. 180:4814-4820. (Pubitemid 28429367)
36. Bischoff M, Dunman P, Kormanec J, Macapagal D, Murphy E, Mounts W, Berger-Bachi B, Projan S. 2004. Microarray-based analysis of the Staphylococcus aureus sigmaB regulon. J. Bacteriol. 186:4085-4099. (Pubitemid 38802556)
37. Engman J, Rogstam A, Frees D, Ingmer H, von Wachenfeldt C. 2012. The YjbH adaptor protein enhances proteolysis of the transcriptional regulator Spx in Staphylococcus aureus. J. Bacteriol. 194:1186-1194.
38. Larsson JT, Rogstam A, von Wachenfeldt C. 2007. YjbH is a novel negative effector of the disulphide stress regulator, Spx, in Bacillus subtilis. Mol. Microbiol. 66:669-684. (Pubitemid 47621855)
39. Kommineni S, Garg SK, Chan CM, Zuber P. 2011. YjbH-enhanced proteolysis of Spx by ClpXP in Bacillus subtilis is inhibited by the small protein YirB (YuzO). J. Bacteriol. 193:2133-2140.
40. Garg SK, Kommineni S, Henslee L, Zhang Y, Zuber P. 2009. The YjbH protein of Bacillus subtilis enhances ClpXP-catalyzed proteolysis of Spx. J. Bacteriol. 191:1268-1277.
41. Nakano S, Kuster-Schock E, Grossman AD, Zuber P. 2003. Spxdependent global transcriptional control is induced by thiol-specific oxidative stress in Bacillus subtilis. Proc. Natl. Acad. Sci. U. S. A. 100:13603-13608. (Pubitemid 37444787)
42. Prepiak P, Defrancesco M, Spadavecchia S, Mirouze N, Albano M, Persuh M, Fujita M, Dubnau D. 2011. MecA dampens transitions to spore, biofilm exopolysaccharide and competence expression by two different mechanisms. Mol. Microbiol. 80:1014-1030.
43. Mei Z, Wang F, Qi Y, Zhou Z, Hu Q, Li H, Wu J, Shi Y. 2009. Molecular determinants of MecA as a degradation tag for the ClpCP protease. J. Biol. Chem. 284:34366-34375.
44. Wang F, Mei Z, Qi Y, Yan C, Xiang S, Zhou Z, Hu Q, Wang J, Shi Y. 2009. Crystal structure of the MecA degradation tag. J. Biol. Chem. 284: 34376-34381.
45. Persuh M, Mandic-Mulec I, Dubnau D. 2002. A MecA paralog, YpbH, binds ClpC, affecting both competence and sporulation. J. Bacteriol. 184: 2310-2313. (Pubitemid 34259683)
46. Falord M, Mader U, Hiron A, Debarbouille M, Msadek T. 2011. Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathways. PLoS One 6:e21323. doi:10.1371/journal.pone.0021323.
47. Dubrac S, Bisicchia P, Devine KM, Msadek T. 2008. A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway. Mol. Microbiol. 70:1307-1322.
48. Burnside K, Lembo A, de Los Reyes M, Iliuk A, Binhtran NT, Connelly JE, Lin WJ, Schmidt BZ, Richardson AR, Fang FC, Tao WA, Rajagopal L. 2010. Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase. PLoS One 5:e11071. doi:10.1371/journal. pone.0011071.
49. Donat S, Streker K, Schirmeister T, Rakette S, Stehle T, Liebeke M, Lalk M, Ohlsen K. 2009. Transcriptome and functional analysis of the eukaryotic-type serine/threonine kinase PknB in Staphylococcus aureus. J. Bacteriol. 191:4056-4069.
50. Anderson KL, Roberts C, Disz T, Vonstein V, Hwang K, Overbeek R, Olson PD, Projan SJ, Dunman PM. 2006. Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover. J. Bacteriol. 188:6739-6756. (Pubitemid 44497886)
51. Schlag S, Nerz C, Birkenstock TA, Altenberend F, Gotz F. 2007. Inhibition of staphylococcal biofilm formation by nitrite. J. Bacteriol. 189: 7911-7919. (Pubitemid 350035099)
52. Muthaiyan A, Silverman JA, Jayaswal RK, Wilkinson BJ. 2008. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrob. Agents Chemother. 52:980-990. (Pubitemid 351358377)
53. Nakano S, Nakano MM, Zhang Y, Leelakriangsak M, Zuber P. 2003. A regulatory protein that interferes with activator-stimulated transcription in bacteria. Proc. Natl. Acad. Sci. U. S. A. 100:4233-4238. (Pubitemid 36418186)
54. Rochat T, Nicolas P, Delumeau O, Rabatinova A, Korelusova J, Leduc A, Bessieres P, Dervyn E, Krasny L, Noirot P. 2012. Genome-wide identification of genes directly regulated by the pleiotropic transcription factor Spx in Bacillus subtilis. Nucleic Acids Res. 40:9571-9583.
55. Leichert LI, Scharf C, Hecker M. 2003. Global characterization of disulfide stress in Bacillus subtilis. J. Bacteriol. 185:1967-1975. (Pubitemid 36297897)
56. Rogstam A, Larsson JT, Kjelgaard P, von Wachenfeldt C. 2007. Mechanisms of adaptation to nitrosative stress in Bacillus subtilis. J. Bacteriol. 189:3063-3071. (Pubitemid 46697395)
57. Gohring N, Fedtke I, Xia G, Jorge AM, Pinho MG, Bertsche U, Peschel A. 2011. New role of the disulfide stress effector YjbH in beta-lactam susceptibility of Staphylococcus aureus. Antimicrob. Agents Chemother. 55:5452-5458.
58. Nakano S, Erwin KN, Ralle M, Zuber P. 2005. Redox-sensitive transcriptional control by a thiol/disulphide switch in the global regulator, Spx. Mol. Microbiol. 55:498-510. (Pubitemid 40179383)
59. Reyes DY, Zuber P. 2008. Activation of transcription initiation by Spx: formation of transcription complex and identification of a cis-acting element required for transcriptional activation. Mol. Microbiol. 69:765-779. (Pubitemid 351962568)
60. Zuber P. 2009. Management of oxidative stress in Bacillus. Annu. Rev. Microbiol. 63:575-597.
61. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810. (Pubitemid 47332566)
62. Kohanski MA, DePristo MA, Collins JJ. 2010. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol. Cell 37:311-320.
63. Liu Y, Imlay JA. 2013. Cell death from antibiotics without the involvement of reactive oxygen species. Science 339:1210-1213.
64. Keren I, Wu Y, Inocencio J, Mulcahy LR, Lewis K. 2013. Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339:1213-1216.
65. Miller C, Thomsen LE, Gaggero C, Mosseri R, Ingmer H, Cohen SN. 2004. SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science 305:1629-1631. (Pubitemid 39296359)
66. Frees D, Savijoki K, Varmanen P, Ingmer H. 2007. Clp ATPases and ClpP proteolytic complexes regulate vital biological processes in low GC, Gram-positive bacteria. Mol. Microbiol. 63:1285-1295.
67. Donegan NP, Thompson ET, Fu Z, Cheung AL. 2010. Proteolytic regulation of toxin-antitoxin systems by ClpPC in Staphylococcus aureus. J. Bacteriol. 192:1416-1422.
68. Chatterjee I, Neumayer D, Herrmann M. 2010. Senescence of staphylococci: using functional genomics to unravel the roles of ClpC ATPase during late stationary phase. Int. J. Med. Microbiol. 300:130-136.
69. Feng J, Michalik S, Varming AN, Andersen JH, Albrecht D, Jelsbak L, Krieger S, Ohlsen K, Hecker M, Gerth U, Ingmer H, Frees D. 2013. Trapping and proteomic identification of cellular substrates of the ClpP protease in Staphylococcus aureus. J. Proteome Res. 12:547-558.
70. Chatterjee I, Schmitt S, Batzilla CF, Engelmann S, Keller A, Ring MW, Kautenburger R, Ziebuhr W, Hecker M, Preissner KT, Bischoff M, Proctor RA, Beck HP, Lenhof HP, Somerville GA, Herrmann M. 2009. Staphylococcus aureus ClpC ATPase is a late growth phase effector of metabolism and persistence. Proteomics 9:1152-1176.
71. Chatterjee I, Maisonneuve E, Ezraty B, Herrmann M, Dukan S. 2011. Staphylococcus aureus ClpC is involved in protection of carbonmetabolizing enzymes from carbonylation during stationary growth phase. Int. J. Med. Microbiol. 301:341-346.
72. Kreiswirth BN, Lofdahl S, Betley MJ, O'Reilly M, Schlievert PM, Bergdoll MS, Novick RP. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:709-712. (Pubitemid 13021519)
73. Stahl ML, Pattee PA. 1983. Confirmation of protoplast fusion-derived linkages in Staphylococcus aureus by transformation with protoplast DNA. J. Bacteriol. 154:406-412. (Pubitemid 13115462)
74. Jousselin A, Renzoni A, Andrey DO, Monod A, Lew DP, Kelley WL. 2012. The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 56:3629-3640.